Evidence map›Paper›PMID 41184370›Full record

ArticleScientific reports2025

Innovative isotopic modeling and risk assessment of PTEs and PAHs in urban soils.

Pegah Parchami, Sima Sabzalipour, Ahad Nazarpour, Maryam Mohammadi Rozbahani, Navid Ghanavati

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pegah ParchamiDepartment of Environmental Sciences, Ahv.C, Islamic Azad University, Ahvaz, Iran.
Sima SabzalipourDepartment of Environmental Sciences, Ahv.C, Islamic Azad University, Ahvaz, Iran.
Ahad NazarpourDepartment of Geology, Ahv.C, Islamic Azad University, Ahvaz, Iran. Ahad.nazarpour@gmail.com.
Maryam Mohammadi RozbahaniDepartment of Environmental Sciences, Ahv.C, Islamic Azad University, Ahvaz, Iran.
Navid GhanavatiDepartment of Soil Sciences, Ahv.C, Islamic Azad University, Ahvaz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the health and environmental risks associated with Potentially Toxic Elements (PTEs) and polycyclic aromatic hydrocarbons (PAHs) in urban soils of Sanandaj City, Iran, using an innovative isotopic modeling approach. A total of 53 surface soil samples were systematically collected, revealing elevated concentrations of Zinc (Zn), Copper (Cu), Nickel (Ni), Cadmium (Cd), Chromium (Cr), Arsenic (As), and Lead (Pb), with Cd posing a significant ecological risk. Ecological risk assessments indicated low risk for most elements, except for Cd, which showed a notable environmental threat. Non-carcinogenic risk assessments, based on ingestion, inhalation, and dermal exposure, revealed no significant risks for both children and adults, although children exhibited higher risks, particularly in ingestion. However, carcinogenic risk assessments demonstrated that metals like Cr, Ni, Pb, Cd, and As exceeded the acceptable risk thresholds for both populations, highlighting a severe health concern. PAH concentrations ranged from 126.44 to 2460.87 µg/kg, with a dominance of high molecular weight PAHs, suggesting significant pyrogenic sources. A novel isotopic modeling method, based on

Indexed as

Polycyclic Aromatic HydrocarbonsSoilSoil PollutantsCitiesEnvironmental MonitoringHumansIranMetals, HeavyRisk AssessmentMetals, HeavyPolycyclic Aromatic HydrocarbonsSoilSoil PollutantsHealth risk assessmentInnovative isotopic modelingLead contaminationPolycyclic aromatic hydrocarbons (PAHs)PTEsUrban soil

Identifiers

PMID41184370
PMCPMC12583582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.